Variant report
Variant | esv3342466 |
---|---|
Chromosome Location | chr16:12723124-12727490 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:12714846..12717275-chr16:12723498..12725575,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539961119 | chr16:12723128-12723129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9930512 | chr16:12723131-12723132 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs145482788 | chr16:12723136-12723137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111866345 | chr16:12723148-12723149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531682219 | chr16:12723155-12723156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369477651 | chr16:12723158-12723159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550100738 | chr16:12723159-12723160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs398028760 | chr16:12723177-12723178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548480568 | chr16:12723178-12723179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568292508 | chr16:12723196-12723197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574685704 | chr16:12723249-12723250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558298778 | chr16:12723251-12723252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182395240 | chr16:12723254-12723255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547076678 | chr16:12723266-12723267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7198104 | chr16:12723272-12723273 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs186675348 | chr16:12723289-12723290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566446220 | chr16:12723290-12723291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143507922 | chr16:12723292-12723293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7197582 | chr16:12723305-12723306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532345874 | chr16:12723311-12723312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12448407 | chr16:12723318-12723319 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs574713626 | chr16:12723319-12723320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540424815 | chr16:12723320-12723321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560202429 | chr16:12723336-12723337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143191979 | chr16:12723348-12723349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11075133 | chr16:12723359-12723360 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs550600044 | chr16:12723362-12723363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs77419081 | chr16:12723366-12723367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562371043 | chr16:12723367-12723368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531314782 | chr16:12723387-12723388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542158529 | chr16:12723401-12723402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561920522 | chr16:12723407-12723408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs74774999 | chr16:12723408-12723409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs117873627 | chr16:12723409-12723410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7359474 | chr16:12723416-12723417 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs532528737 | chr16:12723419-12723420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552626028 | chr16:12723420-12723421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568927001 | chr16:12723421-12723422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537820655 | chr16:12723429-12723430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs77948806 | chr16:12723432-12723433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568373090 | chr16:12723441-12723442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs193268579 | chr16:12723453-12723454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554116088 | chr16:12723457-12723458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536497160 | chr16:12723459-12723460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577344203 | chr16:12723473-12723474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545612448 | chr16:12723485-12723486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147095044 | chr16:12723496-12723497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7359430 | chr16:12723507-12723508 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs113520874 | chr16:12723508-12723509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540968983 | chr16:12723513-12723514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Hodgkin''s lymphoma | 20651079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 22566537 | CNVD |
Intellectual disability | 22566537 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Lung cancer | 18438408 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22102821 | CNVD |
Autism | 22495311 | CNVD |
idiopathic generalized epilepsy | 19843651 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Intellectual disability | 22102821 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Prostate cancer | 18632612 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 19786961 | CNVD |
Mental retardation | 19786961 | CNVD |
Schizophrenia | 19786961 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 18791038 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Autism | 17480035 | CNVD |
Schizophrenia | 19955444 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 17847001 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:12721200-12723600 | Enhancers | A549 | lung |
2 | chr16:12721800-12723200 | Enhancers | HUVEC | blood vessel |
3 | chr16:12723600-12724400 | Enhancers | HepG2 | liver |
4 | chr16:12724400-12734800 | Weak transcription | HepG2 | liver |
5 | chr16:12724800-12725000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |